Immediate release pharmaceutical formulation

Details Immediate release pharmaceutical formulation Immediate release pharmaceutical formulation

A - Human Necessities

61

K

A61K 9/00 (2006.01) A61K 9/08 (2006.01) A61K 9/20 (2006.01) A61K 31/397 (2006.01) A61K 47/10 (2006.01) A61K 47/12 (2006.01) A61K 47/26 (2006.01) A61K 47/40 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2485533

According to the present invention there is provided an immediate release pharmaceutical formulation comprising, as active ingredient, a compound of formula (I), wherein R1 represents C1-2#191 alkyl substituted by one or more fluoro substituents;R2 represents hydrogen, hydroxy, methoxy or ethoxy; andn represents 0, 1 or 2;or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable diluent or carrier; provided that when the active ingredient is other than in the form of a salt the formulation does not solely contain:.bullet. a solution of one active ingredient and water;.bullet. a solution of one active ingredient and dimethylsulphoxide; or.bullet. a solution of one active ingredient in a mixture of ethanol : PEG 660 12-hydroxy stearate : water 5:5:90; such formulations being of use for the treatment of a cardiovascular disorder.

L'invention concerne une formulation pharmaceutique à libération immédiate dont le principe actif est un composé de formule (I), y compris un sel correspondant pharmaceutiquement acceptable. Dans cette formule, R?1¿ est alkyle C¿1-2? substitué par un ou plusieurs substituants fluoro; R?2¿ est hydrogène, hydroxy, méthoxy ou éthoxy; et n vaut 0, 1 ou 2. Ladite formulation comprend aussi un diluant ou un vecteur pharmaceutiquement acceptable. Lorsque le principe actif se présente autrement que sous la forme d'un sel, la formulation ne renferme pas seulement: - une solution de principe actif et d'eau; - une solution de principe actif et de diméthylsulfoxide; ou - une solution de principe actif dans un mélange d'éthanol: PEG 660 12-hydroxy stéarate: eau 5:5:90.. Ce type de formulation se prête au traitement des troubles cardiovasculaires.? ¿

Affiliated with

Also associated with

Rating

Immediate release pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immediate release pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immediate release pharmaceutical formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1473092